The document details pre-market submission requirements for Software as a Medical Device (SaMD) in key jurisdictions: the US, EU, Canada, Japan, Australia, China, Korea, and Singapore. It stresses the importance of mutual understanding between software developers and regulators and specifies the necessary documentation and processes for compliance.
Additionally, it references guidance documents and regulations from other bodies and addresses non-SaMD specific requirements.
Region:Global
Reach out to us and let’s unravel your Regulatory puzzle together. Unlock regulatory solutions with our global subject matter experts and tap into a wealth of regulatory intelligence.
Speak to an Expert